e-learning
resources
European Respiratory Review
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure
Nadia Milad, Mathieu C. Morissette
Source:
Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
Journal Issue:
December
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nadia Milad, Mathieu C. Morissette. Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure. Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Monocyte subpopulations, airway inflammation and lung function in patients with occupational chronic obstructive pulmonary disease from exposure to industrial aerosols containing nanoparticles
Source: Virtual Congress 2020 – Occupational exposure as a cause of respiratory disease
Year: 2020
The role of surfactant on chronic infant lung disease
Source: Annual Congress 2003 - Chronic infant lung disease
Year: 2003
The impact of corticosteroid on the inflammatory mediators in pulmonary and extrapulmonary acute lung injury
Source: Annual Congress 2007 - Acute lung injury and inflammation
Year: 2007
Bacterial load in chronic obstructive pulmonary disease and its relationship with airway inflammation and lung function
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
The role of inflammation in prevalence of chronic obstructive pulmonary diseases in wood workers
Source: Eur Respir J 2007; 30: Suppl. 51, 599s
Year: 2007
The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases
Source: Eur Respir Monogr 2017; 77: 224-246
Year: 2017
Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
How systemic inflammatory diseases affect the lung
Source: Virtual Congress 2020 – Interstitial lung diseases
Year: 2020
The impact of airborne occupational exposure in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - The impact of airborne occupational exposure in COPD
Year: 2010
COPD as a lung disease with heterogeneous systemic inflammatory consequences: clinical impact
Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD
Year: 2011
The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease
Source: International Congress 2018 – Scientific Year in Review
Year: 2018
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019
The role of prooxidant effect of metals with variable valiancy in pathogenesis of chronic obstructive diseases of lungs
Source: Eur Respir J 2002; 20: Suppl. 38, 96s
Year: 2002
Role of systemic and bronchial oxidative stress and inflammation in lung cancer predisposition in patients with COPD
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Effect of 3-week pulmonary rehabilitation on airway inflammation in patients with chronic obstructive lung diseases
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Early-life pulmonary immunity and development of paediatric inflammatory respiratory diseases
Source: International Congress 2019 – Early origins of lung disease: an interdisciplinary approach
Year: 2019
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept